Snapshot from Jul 07, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Gilead Sciences / Merck & Co.

Gilead Sciences & Merck & Co.

2 shared events · Importance 4 · Last updated Jun 03, 2026

Importance
4
Shared Events
2
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (2)
85
Regulatory
Trump Secures Drug Price Deals
Gilead Sciences: Gilead Sciences is among the pharmaceutical companies that agreed to lower drug prices for United States — Medicaid and cash payers as part of the deals with the Donald Trump administration.
Merck & Co.: Merck & Co. struck a deal to cut prices, committing to sell its diabetes drugs Januvia, Janumet, and Janumet XR at 70% off list prices directly to US consumers and pledging $70 billion in US R&D and manufacturing investments.
Dec 19, 2025 · 7 articles
0
Business
Biotech M&A Surges Amid Patent Cliffs
Gilead Sciences: Gilead Sciences is a pharmaceutical company that has been actively involved in acquisitions this year and is also facing patent expirations on some of its blockbuster drugs.
May 01, 2026 · 6 articles
NEWSDESK
Explore this relationship live

Track how Gilead Sciences and Merck & Co. interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.